UFP Technologies, Inc. Share-based Payment Arrangement, Expense
UFP Technologies, Inc. (UFPT) reported Share-based Payment Arrangement, Expense of $3.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-06
- UFP Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.22M, a 41.09% increase year-over-year.
- UFP Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $2.73M, a 23.55% increase year-over-year.
- UFP Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $2.40M, a 16.69% increase year-over-year.
- UFP Technologies, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $1.96M, a 27.29% increase year-over-year.
- UFP Technologies, Inc. share-based payment arrangement, expense for fiscal 2025 was $8.85M, a 29.41% increase from fiscal 2024.
- UFP Technologies, Inc. share-based payment arrangement, expense for fiscal 2024 was $6.84M, a 47.43% increase from fiscal 2023.
- UFP Technologies, Inc. share-based payment arrangement, expense for fiscal 2023 was $4.64M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $3.22M 10-Q · filed 2026-08-06 | $5.96M 10-Q · filed 2026-08-06 | $8.36M derived: sum of 3 quarters · filed 2026-08-06 | $10.31M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $2.73M 10-Q · filed 2026-05-08 | $5.13M derived: sum of 2 quarters · filed 2026-05-08 | $7.09M derived: sum of 3 quarters · filed 2026-05-08 | $9.38M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $4.36M derived: sum of 2 quarters · filed 2026-02-27 | $6.64M derived: sum of 3 quarters · filed 2026-08-06 | $8.85M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $1.96M 10-Q · filed 2025-11-07 | $4.24M derived: sum of 2 quarters · filed 2026-08-06 | $6.46M 10-Q · filed 2025-11-07 | $8.51M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $2.29M 10-Q · filed 2026-08-06 | $4.50M 10-Q · filed 2026-08-06 | $6.55M derived: sum of 3 quarters · filed 2026-08-06 | $8.09M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $2.21M 10-Q · filed 2026-05-08 | $4.27M derived: sum of 2 quarters · filed 2026-05-08 | $5.81M derived: sum of 3 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $2.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.59M derived: sum of 2 quarters · filed 2026-02-27 | $6.84M 10-K · filed 2026-02-27 | ||
| 2024-09-30 | $1.54M 10-Q · filed 2025-11-07 | $4.79M 10-Q · filed 2025-11-07 | |||
| 2023-12-31 | $4.64M 10-K · filed 2026-02-27 | ||||
| 2016-06-30 | $441.00K 10-Q · filed 2016-08-09 | $642.00K 10-Q · filed 2016-08-09 | |||
| 2016-03-31 | $201.00K 10-Q · filed 2016-05-09 | ||||
| 2015-09-30 | $226.00K 10-Q · filed 2015-11-06 | $662.00K derived: sum of 2 quarters · filed 2016-08-09 | $873.00K 10-Q · filed 2015-11-06 | ||
| 2015-06-30 | $436.00K 10-Q · filed 2016-08-09 | $647.00K 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | $210.00K 10-Q · filed 2016-05-09 | ||||
| 2014-09-30 | $215.00K 10-Q · filed 2015-11-06 | $680.00K derived: sum of 2 quarters · filed 2015-11-06 | $945.00K 10-Q · filed 2015-11-06 | ||
| 2014-06-30 | $465.00K 10-Q · filed 2015-08-07 | $730.00K 10-Q · filed 2015-08-07 | |||
| 2014-03-31 | $265.00K 10-Q · filed 2015-05-08 | ||||
| 2013-09-30 | $200.00K 10-Q · filed 2014-11-07 | $528.00K derived: sum of 2 quarters · filed 2014-11-07 | $707.00K 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | $328.00K 10-Q · filed 2014-08-08 | $507.00K 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | $179.00K 10-Q · filed 2014-05-12 | $179.34K 10-Q · filed 2013-05-10 | |||
| 2012-09-30 | $182.29K 10-Q · filed 2012-11-09 | $492.44K derived: sum of 2 quarters · filed 2012-11-09 | $679.34K 10-Q · filed 2012-11-09 | ||
| 2012-06-30 | $310.15K 10-Q · filed 2012-08-09 | $497.05K 10-Q · filed 2012-08-09 | |||
| 2012-03-31 | $186.90K 10-Q · filed 2013-05-10 | ||||
| 2011-09-30 | $228.65K 10-Q · filed 2012-11-09 | $610.67K derived: sum of 2 quarters · filed 2012-11-09 | $860.01K 10-Q · filed 2012-11-09 | ||
| 2011-06-30 | $382.02K 10-Q · filed 2012-08-09 | $631.36K 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |